User: Guest  Login
Title:

c-Met in chromophobe renal cell carcinoma.

Document type:
Journal Article; Article
Author(s):
Erlmeier, Franziska; Ivanyi, Philipp; Hartmann, Arndt; Autenrieth, Michael; Wiedemann, Max; Weichert, Wilko; Steffens, Sandra
Abstract:
c-Met plays a role as a prognostic marker in clear cell renal cell carcinoma. In addition, recently the tyrosine kinase inhibitor cabozantinib targeting c-Met was approved for the treatment of advanced renal cell carcinoma (RCC). In contrast to clear cell RCC, little is known about c-Met expression patterns in rarer RCC subtypes. The aim of this study was to evaluate the prevalence, distribution and prognostic impact of c-Met expression on chromophobe (ch)RCC. Patients who underwent renal surger...     »
Journal title abbreviation:
Med Oncol
Year:
2017
Journal volume:
34
Journal issue:
2
Pages contribution:
15
Language:
eng
Fulltext / DOI:
doi:10.1007/s12032-016-0874-1
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/28035577
Print-ISSN:
1357-0560
TUM Institution:
Institut für Allgemeine Pathologie und Pathologische Anatomie; Urologische Klinik und Poliklinik
 BibTeX